Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05853965 |
|---|---|
| Brief Title: | Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma (BELI(E)VE) |
| First Submitted : | April 22, 2023 |
| First Submitted that Met QC Criteria : | May 10, 2023 |
| First Posted : | May 11, 2023 |
| Last Update Submitted that Met QC Criteria : | July 17, 2023 |
| Last Update Posted : | July 19, 2023 |